145 related articles for article (PubMed ID: 3530455)
1. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W
Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455
[No Abstract] [Full Text] [Related]
2. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Greco A; Prestridge K; Johnson R
Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833
[No Abstract] [Full Text] [Related]
4. Phase II trial of acivicin in advanced metastatic breast cancer.
Fleishman G; Yap HY; Murphy WK; Bodey G
Cancer Treat Rep; 1983 Sep; 67(9):843-4. PubMed ID: 6883364
[No Abstract] [Full Text] [Related]
5. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
Maroun JA; Fields AL; Pater JL; Stewart DJ; Cripps C; Eisenhauer E
Cancer Treat Rep; 1984 Sep; 68(9):1121-3. PubMed ID: 6478451
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study.
Maroun JA; Maksymiuk A; Eisenhauer E; Stewart DJ; Young V; Pater J
Cancer Treat Rep; 1986 Nov; 70(11):1327-8. PubMed ID: 3021326
[TBL] [Abstract][Full Text] [Related]
7. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
Gockerman JP; Raney M; Logan T
Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
[No Abstract] [Full Text] [Related]
8. Phase I study of acivicin in patients with advanced cancer.
Sridhar KS; Ohnuma T; Chahinian AP; Holland JF
Cancer Treat Rep; 1983; 67(7-8):701-3. PubMed ID: 6871885
[No Abstract] [Full Text] [Related]
9. Phase II trial of acivicin in malignant mesothelioma.
Falkson G; Vorobiof DA; Simson IW; Borden EC
Cancer Treat Rep; 1987 May; 71(5):545-6. PubMed ID: 3567981
[No Abstract] [Full Text] [Related]
10. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
[No Abstract] [Full Text] [Related]
11. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Fiore J; Kemeny N; Raymond V; Young C
Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
[No Abstract] [Full Text] [Related]
12. Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
McGuire WP; Blessing JA; DiSaia PJ; Buchsbaum HJ
Invest New Drugs; 1986; 4(1):49-52. PubMed ID: 3700040
[TBL] [Abstract][Full Text] [Related]
13. Phase I-II trial of acivicin in adult acute leukemia.
Powell BL; Craig JB; Capizzi RL; Richards F
Invest New Drugs; 1988 Apr; 6(1):41-4. PubMed ID: 3165971
[TBL] [Abstract][Full Text] [Related]
14. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny NE; Gralla RJ
Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
[No Abstract] [Full Text] [Related]
15. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
[No Abstract] [Full Text] [Related]
16. Phase II evaluation of pyrazofurin in patients with metastatic sarcoma.
Gralla RJ; Sordillo PP; Magill GB
Cancer Treat Rep; 1978 Oct; 62(10):1573-4. PubMed ID: 361228
[No Abstract] [Full Text] [Related]
17. Phase II evaluation of piperazinedione in metastatic breast carcinoma.
Palmer RL; Samal BA; Vaughn CB; Tranum BL
Cancer Treat Rep; 1977 Dec; 61(9):1711-2. PubMed ID: 340035
[No Abstract] [Full Text] [Related]
18. Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
Earhart RH; Khandekar JD; Faraggi D; Schinella RA; Davis TE
Invest New Drugs; 1989 Jul; 7(2-3):255-60. PubMed ID: 2793383
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of acivicin in patients with advanced colorectal carcinoma.
Adolphson CC; Ajani JA; Stroehlein JR; Barlogie B; Bodey GP; Korinek J; Bedikian AY
Am J Clin Oncol; 1986 Jun; 9(3):189-91. PubMed ID: 3728371
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of pyrazofurin in patients with carcinoma of the lung.
Gralla RJ; Currie VE; Wittes RE; Golbey RB; Young CW
Cancer Treat Rep; 1978 Mar; 62(3):451-2. PubMed ID: 348315
[No Abstract] [Full Text] [Related]
[Next] [New Search]